Immunotherapy for Epstein-Barr virus-associated cancers.

Journal of the National Cancer Institute. Monographs

Volumn , Issue 23, 1998, Pages 89-93

  Rooney, C M ^a   Roskrow, M A ^a   Smith, C A ^a   Brenner, M K ^a   Heslop, H E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ARTICLE; B LYMPHOCYTE; CHEMICALLY INDUCED DISORDER; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HODGKIN DISEASE; HUMAN; IMMUNOLOGY; LYMPHOPROLIFERATIVE DISEASE; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOPROLIFERATIVE DISORDERS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS;

EID: 0031622993     PISSN: 10526773     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jncimonographs.a024180     Document Type: Article

References (0)